1. Ready to scale
Currently, Sidekick is growing rapidly; the company has grown from 20 to 60 people recently, and plans to continue to scale in 2021. Suffice it to say that this explosive growth has kept the team busy.
2. Well-positioned to enter the U.S. market
Looking ahead, Sidekick has its sights set on tapping into the U.S. market. To do that, they will need to secure FDA approval on some products as a software as a medical device organization.
“Being a European company, a lot of U.S. policies and procedures are quite foreign to us,” Gylfason explains. “This is a strong selling point for Qualio; the platform helps you through the process step by step. I can’t recommend that enough. It was a real burden off of our shoulders.”
3. High-touch onboarding
Shortly after Gylfason was onboarded by the Qualio staff, the Sidekick team hired a key position on the Quality team, and the company decided to hand over Qualio ownership to that individual.
“Her onboarding process was the same as mine,” Gylfason continues. “Someone from the Qualio team onboarded her instead of me having to train her. That way, she was more confident in the system.”
One of the main selling points of Qualio is the fact that it enables Sidekick to operate from an audit-ready stance at all times.
“That helped us get the sign off from our CFO,” Gylfason explains. “We haven’t been audited yet, but it’s only a matter of time. During the summer or fall, we’re planning on contacting auditors and asking them to audit us proactively.”
Thanks to Qualio’s audit-readiness, the Sidekick team is confident those audits won’t be an issue.